PADCEV Patient Assistance Program

The PADCEV Patient Assistance Programa (PAP) provides PADCEVTM (enfortumab vedotin-ejfv) at no cost to uninsured patients who meet the program eligibility requirements.

Eligibility Requirements

PADCEV Support SolutionsSM will evaluate a patient's eligibility for the PAP program.
For more information, contact us at 1‑888‑402‑0627. We are available Monday–Friday, 8:30 am–8:00 pm ET.

Your patient may be eligible for the PAP program if he or she:

  • Does not have insurance or has insurance that excludes coverage for PADCEV,a
  • Has a verifiable shipping address in the United States,
  • Has been prescribed PADCEV for an FDA-approved indication, AND
  • Meets the program financial eligibility requirements

Application Process

Complete the Patient Enrollment Form, including all signatures, and either upload it through the Prescriber Portal or fax it to 1‑877‑747‑6843. If the patient is eligible for the PAP program, we will notify you and the patient.

PADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM.

aProgram subject to eligibility restrictions and program terms and conditions.

PADCEVTM is a trademark jointly owned by Agensys, Inc. and Seattle Genetics, Inc.